Profile for China Patent: 101903324
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for China Patent: 101903324
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Dec 15, 2028 | United Therap | REMODULIN | treprostinil |
| ⤷ Start Trial | Dec 15, 2028 | United Therap | TYVASO DPI | treprostinil |
| ⤷ Start Trial | Dec 15, 2028 | United Therap | TYVASO | treprostinil |
| ⤷ Start Trial | Dec 15, 2028 | United Therap | ORENITRAM | treprostinil diolamine |
| ⤷ Start Trial | Dec 15, 2028 | United Therap | ORENITRAM | treprostinil diolamine |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
